Comment on

• Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.

  [No authors listed] [No authors listed] Lancet. 1996 Mar 2;347(9001):561-8. Lancet. 1996. PMID: 8596317 Clinical Trial.
• Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators.

  [No authors listed] [No authors listed] Lancet. 1999 Aug 28;354(9180):708-15. Lancet. 1999. PMID: 10475181 Clinical Trial.
• Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis.

  Eikelboom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S. Eikelboom JW, et al. Lancet. 2000 Jun 3;355(9219):1936-42. doi: 10.1016/S0140-6736(00)02324-2. Lancet. 2000. PMID: 10859038